The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …

D Simons, L Shahab, J Brown, O Perski - Addiction, 2021 - Wiley Online Library
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …

Impact of obesity on COVID-19 patients

W Yu, KE Rohli, S Yang, P Jia - Journal of Diabetes and its Complications, 2021 - Elsevier
With the increasing prevalence of obesity, there is a growing awareness of its impact on
infectious diseases. In past epidemics of influenza A and Middle East respiratory syndrome …

Neurological manifestations of COVID-19–an approach to categories of pathology

Y Leven, J Bösel - Neurological research and practice, 2021 - Springer
Background Various neurological manifestations of infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have been reported, associated with a broad …

[HTML][HTML] S2k-Leitlinie–Empfehlungen zur stationären Therapie von Patienten mit COVID-19

S Kluge, U Janssens, T Welte, S Weber-Carstens… - …, 2021 - thieme-connect.com
Seit Dezember 2019 verbreitet sich das neuartige Coronavirus SARS-CoV-2 (Severe Acute
Respiratory Syndrome–Corona Virus-2) rasch im Sinne einer weltweiten Pandemie. Dies …

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

V Glück, S Grobecker, L Tydykov, B Salzberger… - Infection, 2021 - Springer
Objective To follow serological immune responses of front-line healthcare workers after PCR-
confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 …

Can we predict the severe course of COVID-19-a systematic review and meta-analysis of indicators of clinical outcome?

S Katzenschlager, AJ Zimmer, C Gottschalk… - PLoS …, 2021 - journals.plos.org
Background COVID-19 has been reported in over 40million people globally with variable
clinical outcomes. In this systematic review and meta-analysis, we assessed demographic …

The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

M Schons, L Pilgram, JP Reese, M Stecher… - European Journal of …, 2022 - Springer
The German government initiated the Network University Medicine (NUM) in early 2020 to
improve national research activities on the Severe Acute Respiratory Syndrome Coronavirus …

Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity

D Munker, T Veit, J Barton, P Mertsch, C Mümmler… - Infection, 2022 - Springer
Objective Evaluation of pulmonary function impairment after COVID-19 in persistently
symptomatic and asymptomatic patients of all disease severities and characterisation of risk …

Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies

AJ Scheen - Diabetes & Metabolism, 2021 - Elsevier
Aims People with cardiovascular disease or risk factors are at increased risk when exposed
to SARS-CoV-2. Most are treated with statins, but the impact of these drugs on clinical …

Harmonization and standardization of data for a pan-European cohort on SARS-CoV-2 pandemic

E Rinaldi, C Stellmach, NMR Rajkumar… - NPJ Digital …, 2022 - nature.com
The European project ORCHESTRA intends to create a new pan-European cohort to rapidly
advance the knowledge of the effects and treatment of COVID-19. Establishing processes …